Literature DB >> 24820730

Endoscopic transsphenoidal treatment of a prolactinoma patient with brain and optic chiasmal herniations.

Ning Zhang1, Liemei Guo, Jianwei Ge, Yongming Qiu.   

Abstract

Bromocriptine has been the most widely used and effective agent to treat macroprolactinoma, and chiasmal herniation in a macroprolactinoma patient following the treatment with bromocriptine is a well-recognized complication. However, herniation of the inferior mesial frontal lobe into the sella has been rarely reported. The present clinical report is the second radiographic demonstration of herniation of the inferior mesial frontal lobe into the sella. After the treatment with transsphenoidal endoscopic chiasmopexy, the patient's visual disturbance improved dramatically. We suggest that transsphenoidal endoscopic chiasmopexy is an effective treatment option for the prolactinoma patient with brain and chiasmal herniations following the treatment with bromocriptine.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24820730     DOI: 10.1097/SCS.0000000000000632

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  3 in total

1.  Brain and Optic Chiasm Herniation into Sella after Pituitary Tumor Apoplexy.

Authors:  Maria M Pineyro; Patricia Furtenbach; Ramiro Lima; Saul Wajskopf; Nicolas Sgarbi; Raul Pisabarro
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-07       Impact factor: 5.555

2.  Surgical management of anterior clinoidal meningiomas: consensus statement on behalf of the EANS skull base section.

Authors:  D Starnoni; C Tuleasca; L Giammattei; G Cossu; M Bruneau; M Berhouma; J F Cornelius; L Cavallo; S Froelich; E Jouanneau; T R Meling; D Paraskevopoulos; H Schroeder; M Tatagiba; I Zazpe; A Sufianov; M E Sughrue; Ari G Chacko; V Benes; P González-Lopez; Pierre-Hugues Roche; Marc Levivier; Mahmoud Messerer; Roy T Daniel
Journal:  Acta Neurochir (Wien)       Date:  2021-08-16       Impact factor: 2.216

3.  Chiasmal herniation following treatment of pituitary macroadenoma.

Authors:  Marjolein Tabak; Iris C M Pelsma; Mark C Kruit; Wouter R van Furth; Nienke R Biermasz; Irene C Notting
Journal:  Pituitary       Date:  2020-10-15       Impact factor: 4.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.